Metronidazole 375 mg capsules are a distinct oral prescription product family in the United States. Both FLAGYL 375 brand labeling and generic 375 mg capsule labeling can be found in official drug records. Their defining features are not just the metronidazole ingredient and the number 375: the oral capsule dosage form, capsule strength, product label and prescription all need to agree before a pharmacy fills an order.
Capsule searches often mix the 375 mg product with 250 mg and 500 mg immediate-release tablets, 750 mg extended-release tablets or historical Flagyl brand references. These products cannot be treated as automatically interchangeable. A clinician should determine which formulation and regimen are appropriate; a patient should not use a strength conversion to switch dosage forms. Our oral formulation hub explains the wider family and tablet comparison explains why tablets are a different product category.
This page focuses on recognizing a 375 mg capsule, interpreting the Flagyl-to-generic relationship and checking what a pharmacy is actually dispensing. A recent DailyMed label does not confirm that a particular capsule package is on a local shelf. For practical questions about prescription fulfillment, consult the oral metronidazole pharmacy guide after a valid prescription has been issued.
The 375 mg number identifies the amount of metronidazole in one oral capsule. The capsule is a dosage form with its own inactive ingredients, appearance, packaging and prescribing information. The official FLAGYL 375 label identifies a capsule product, not a standard 375 mg immediate-release tablet. This distinction should be visible on a well-described pharmacy listing.
A patient who receives a container marked 375 mg should also verify that it specifies capsules and oral use. Manufacturer and imprint information can help confirm the product. The strength alone does not identify a treatment regimen or establish that the capsule is the product a clinician intended for a specific diagnosis.
| Question | 375 mg capsule answer | What to verify |
|---|---|---|
| What is the product? | Oral metronidazole capsule | Capsule wording and 375 mg strength |
| Is FLAGYL 375 a tablet? | No, it is a capsule presentation | Branded versus generic capsule label |
| Does a 500 mg tablet replace it? | Not automatically | Prescriber and pharmacist authorization |
| Is this metronidazole ER? | Not the 750 mg ER tablet family | Release designation and prescription |
| Does an NDC show local stock? | No | Ask the dispensing pharmacy directly |
The official FLAGYL capsule label identifies metronidazole 375 mg in an oral capsule, along with product-specific contents and package details. That is useful for understanding what the branded name refers to. It should not be confused with the FDA's discontinued listings for the branded 250 mg and 500 mg FLAGYL tablet presentations, which are different products.
A label's presence on DailyMed is not a promise of fresh inventory and should not be transformed into a “buy branded capsules now” claim. A pharmacy can determine whether it is able to order or dispense the actual branded or generic capsule product that matches the written prescription. For the broader historical distinction, see Flagyl brand and product status.
Generic 375 mg capsule products should be evaluated against the proper reference capsule formulation, not simply against any metronidazole tablet. FDA generic approval considers relevant requirements including form, strength, route and bioequivalence. Distinct labelers may distribute approved presentations whose colors, imprints or packaging are not identical.
Before accepting a substituted capsule, ask the pharmacist which generic is being dispensed and whether it is appropriate under the prescription and applicable rules. An Orange Book listing can support regulatory comparison, while the pharmacy is responsible for actual dispensing. The generic guide details approval and substitution boundaries.
The availability of 250 mg or 500 mg tablets does not establish that those tablets may replace a 375 mg capsule in an individual order. A 375 mg capsule is a separately labeled dosage form, and prescribed instructions can depend on the formulation. A numerical relationship between milligrams cannot authorize a change in the treatment plan.
Likewise, the 750 mg extended-release tablet differs by formulation as well as amount of drug. A patient seeing “ER” on a shopping page should not assume it describes a higher dose of their capsule. When the pharmacy cannot source the prescribed item, the pharmacist should consult the prescriber rather than asking the patient to design a substitute.
A helpful label check covers the ingredient, 375 mg strength, capsule form, oral route, directions, quantity and dispensing source. A generic manufacturer or labeler name may differ from the familiar brand; that difference is not by itself proof of an error. Compare the details with the prescription and ask the pharmacist about any unfamiliar appearance.
Capsule contents, shell ingredients and labeling are formulation-specific. A patient with known ingredient sensitivities or trouble swallowing capsules should raise those concerns before attempting to open or alter the medicine. Any change to administration requires professional review of the particular product label.
A valid prescription is required regardless of whether the clinician writes Flagyl 375 or generic metronidazole capsules. The pharmacist checks the dosage form, strength, any brand-substitution directions and the product obtainable through the pharmacy. Electronic ordering systems can display several metronidazole forms, so the route and form deserve explicit confirmation.
Supply can vary across pharmacies and over time. If a seller claims branded 375 mg capsules are universally available, ask for the exact labeled item and independent verification rather than relying on a static promotional claim. The oral availability page explains how to check current listings without inventing stock.
The capsule is a prescription systemic antimicrobial and carries metronidazole-related warnings, interactions and adverse-effect information. A prescriber may need to consider patient history, other medicines and susceptibility of the condition being treated. Capsule labeling should be consulted directly rather than assuming all metronidazole products have identical directions.
Use the medication only as instructed for the diagnosed condition. Do not share capsules, resume an old course or take extra units to approximate a tablet regimen. Questions about swallowing, missed doses or possible reactions should be handled with the prescriber or pharmacist.
When an advertisement uses Flagyl 375, ask whether the listed product is a branded metronidazole capsule, an FDA-approved generic 375 mg capsule, or simply an old reference name used as a search keyword. The description should specify the capsule dosage form and identify who is responsible for dispensing it. A product page lacking the actual formulation or prescription requirements should not be considered reliable just because it displays a familiar brand name.
Also distinguish an official label from a transaction claim. DailyMed provides clinical and product labeling, while a licensed pharmacy can answer whether a particular item can be filled today. A genuine label does not promise stock, a particular price or permission to use the capsule for an unrelated condition. These questions are especially valuable for a dosage form that is less recognizable than 250 mg and 500 mg tablets.
A patient's ability to use the prescribed dosage form is a legitimate reason to talk with the treating clinician or pharmacist before dispensing. Do not assume a capsule can be opened, sprinkled on food or converted into a liquid without checking the specific labeled product. The inactive ingredients and capsule design belong to the actual formulation being supplied, not to every medicine with the ingredient metronidazole.
If an oral suspension is a consideration, the clinician must decide whether it meets the clinical need and the pharmacy must verify the concentration and instructions. An approved suspension is a different dosage form with its own labeling; a compounded liquid may be prepared under separate rules. No patient should be asked to invent a volume or regimen based on the capsule strength alone.
Confirm that the prescription specifies metronidazole oral capsules and the 375 mg strength. Then compare the pharmacy listing and final container for form, ingredient, directions and quantity. Determine whether the order permits an approved generic and ask about any difference in labeler or packaging.
If the ordered capsule is unavailable, seek professional clarification instead of changing the form yourself. A current market database or manufacturer label is useful evidence for product identity but not a live local inventory report. The safest result is a correctly identified, properly dispensed prescription medicine.
A documented U.S. oral product is a metronidazole 375 mg capsule, available in brand-associated and generic labeling. It is a prescription medicine.
Yes. U.S. FLAGYL 375 labeling describes an oral capsule containing 375 mg of metronidazole.
No. They differ in strength and dosage form. Patients must not alter the formulation or create a substitute course themselves.
U.S. branded and generic capsule labels and approval records can be consulted to verify product identity. Approval does not guarantee a particular manufacturer’s current pharmacy stock.
No. FDA marketing status for branded 250 mg and 500 mg tablets should not be transferred automatically to the distinct 375 mg capsule product.
Do not assume so. Metronidazole 750 mg extended-release tablets are a different product family with separate labeling.
A pharmacist may be able to dispense an appropriately approved equivalent when the prescription and applicable rules allow. The exact form and strength still must match.
No. Generic products may vary in appearance and packaging. A pharmacist can confirm the labeled identity, imprint and manufacturer.
The pharmacist can explain what options are authorized and whether prescriber clarification or a new order is needed. Do not decide on a tablet substitute yourself.
Check metronidazole, 375 mg, oral capsule dosage form, directions, quantity and any permitted brand/generic substitution with the dispensing pharmacist.